Metastatic gastric cancer – focus on targeted therapies
Judith Meza-Junco, Michael B SawyerDepartment of Oncology, Cross Cancer Institute, Edmonton, Alberta, CanadaAbstract: Gastric cancer (GC) is currently the second leading cause of cancer death worldwide; unfortunately, most patients will present with locally advanced or metastatic disease. Despite re...
Enregistré dans:
Auteurs principaux: | Meza-Junco J, Sawyer MB |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/099185f5e7a940028ffa23aae2ec4e4e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Targeted therapy using nanotechnology: focus on cancer
par: Sanna V, et autres
Publié: (2014) -
Novel microtubule-targeting agents – the epothilones
par: Daniel R Budman, et autres
Publié: (2008) -
New treatment options in the management of IBD – focus on colony stimulating factors
par: Josué Barahona-Garrido, et autres
Publié: (2008) -
Application of liposomes in drug development – focus on gastroenterological targets
par: Zhang JX, et autres
Publié: (2013) -
Nanocalcium-deficient hydroxyapatite–poly (ε-caprolactone)–polyethylene glycol–poly (ε-caprolactone) composite scaffolds
par: Wang Z, et autres
Publié: (2012)